Lung Collapse With Bronchial Blocker
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT01615263 |
|
Recruitment Status :
Completed
First Posted : June 8, 2012
Results First Posted : September 19, 2013
Last Update Posted : March 27, 2014
|
- Study Details
- Tabular View
- Study Results
- Disclaimer
- How to Read a Study Record
| Condition or disease | Intervention/treatment | Phase |
|---|---|---|
| Video-assisted Thoracoscopic Surgery Lung Isolation Device One-lung Ventilation Double Lumen Endotracheal Tube Bronchial Blocker | Device: Lung isolation device | Not Applicable |
Show detailed description
| Study Type : | Interventional (Clinical Trial) |
| Actual Enrollment : | 40 participants |
| Allocation: | Randomized |
| Intervention Model: | Parallel Assignment |
| Masking: | Single (Care Provider) |
| Official Title: | Isolated Lung Collapse in Two Stages With Bronchial Blocker: Comparison With Double Lumen Tube |
| Study Start Date : | April 2012 |
| Actual Primary Completion Date : | October 2012 |
| Actual Study Completion Date : | December 2012 |
| Arm | Intervention/treatment |
|---|---|
|
Active Comparator: Double lumen tube
Lung isolation with a left double lumen tube (BronchoCath, Mallinckrodt Medical, Cornamaddy, Athlone, Westmeath, Ireland.
|
Device: Lung isolation device
Lung isolation for one-lung ventilation with a left double lumen tube
Other Name: BronchoCath, Mallinckrodt Medical |
|
Active Comparator: Bronchial blocker
Lung isolation with a bronchial blocker with the inner channel closed (Fuji Uniblocker 9F, Fuji System Corporation, Tokyo, 113-0033, Japan) inserted via a 8.0 mm simple lumen endotracheal tube.
|
Device: Lung isolation device
Lung isolation for one-lung ventilation with a bronchial blocker inserted through a 8.0 mm simple lumen endotracheal tube
Other Name: Fuji Uniblocker 9 French |
- Time to Obtain Complete Lung Collapse [ Time Frame: From the beginning of one lung ventilation to 20 minutes after pleural opening ]For patients intubated with double lumen tube (DLT), clamping of the ipsilateral lumen without continuous positive airway pressure (CPAP) on the isolated lung will be done to allow lung collapse. The timer will be started at this moment and stopped 20 minutes after pleural opening. For patients of the bronchial blocker (BB) group, the first apnea period will of 30 seconds, keeping a pulse oximetry (SpO2) always over 97%, and under direct visualization with the FOB. Afterward, the cuff will be reflated and the timer will be started at this moment and stopped 20 minutes after pleural opening. For both groups, time of total lung collapse will be measured.
- Quality of Lung Collapse [ Time Frame: From pleural opening to 20 minutes after ]
Assessment of lung collapse by the thoracic surgeon at 0, 5, 10 and 20 minutes after pleural opening.Visual analog scale of the quality of lung collapse will be assessed as the following:
- No lung collapse
- Partial lung collapse, not satisfactory
- Partial lung collapse, satisfactory
- Complete lung collapse
- Opinion on the Device [ Time Frame: 20 minutes after pleural opening ]20 minutes after pleural opening, the thoracic surgeon will give his opinion on the lung isolation device that was used on his patient (double lumen tube or bronchial blocker).
- Use of Suction to Facilitate Lung Collapse [ Time Frame: Up to 5 minutes after surgery ]
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
| Ages Eligible for Study: | 18 Years and older (Adult, Older Adult) |
| Sexes Eligible for Study: | All |
| Accepts Healthy Volunteers: | No |
Inclusion Criteria:
- signed informed consent
- elective video-assisted thoracoscopy
- one lung ventilation
Exclusion Criteria:
- Difficult mask ventilation
- planned difficult intubation
- use of a right double lumen tube
- severe COPD (VEMS < 50% and Tiffeneau < 50% of the predicted values)
- asthma (instable <1 year)
- bulla disease
- pleural disease
- previous ipsilateral thoracic surgery
- thoracic radiotherapy
- significant systemic co-morbidity
- active or chronic pulmonary infection
- fibrosis, other interstitial diseases
- endobronchial mass
- right upper lobe bronchus at the pericarinal level (preoperative or at the first FOB under anesthesia)
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01615263
| Canada, Quebec | |
| Institut universitaire de cardiologie et de pneumologie de Québec | |
| Québec, Quebec, Canada, G1V 4G5 | |
| Principal Investigator: | Jean S Bussières, MD | Laval University |
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
| Responsible Party: | Jean Bussières, Anesthesiologist, Full clinical professor, Laval University |
| ClinicalTrials.gov Identifier: | NCT01615263 |
| Other Study ID Numbers: |
IUCPQ 20784 |
| First Posted: | June 8, 2012 Key Record Dates |
| Results First Posted: | September 19, 2013 |
| Last Update Posted: | March 27, 2014 |
| Last Verified: | February 2014 |
|
Video-assisted thoracoscopic surgery (VATS) One lung ventilation Bronchial blocker Lung collapse Double lumen tube |
|
Pulmonary Atelectasis Shock Pathologic Processes Lung Diseases Respiratory Tract Diseases |

